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Abstract To eliminate the risk of colorectal cancer in
patients with familial adenomatous polyposis (FAP), recon-
structive proctocolectomy is performed. Although most
colonic mucosa is resected during the ileal pouch anal
anastomosis, adenomas and carcinomas may develop in the
pouch. This may be caused by altered cell kinetics due to
intraluminal changes in the pouch. In 32 patients with FAP,
biopsy specimens from the mucosa of the pouch and also of
the afferent ileal loop were taken. Tissue sections were
immunohistochemically processed with the monoclonal
antibodies M30 and MIB-1 to assess apoptotic and
proliferative indices, respectively. Cell proliferation was
also assessed by a modified sign test. There were no
significant differences in apoptotic rates between the
mucosa of the pouch and the mucosa of the afferent ileal
loop. However, cell proliferation was significantly higher in
the mucosa of the pouch vs afferent ileal loop, both by
using the quantitative (68.3% vs 61.6%, p=0.001) and
semiquantitative methods (p<0.05). Our newly developed
semiquantitative approach outperformed previously de-
scribed methods. The higher cell proliferation in the pouch
as compared to the afferent ileal loop may contribute to the
increased risk for adenomas and carcinomas in the pouch of
patients with FAP and emphasizes the need for regular
endoscopic surveillance.
Keywords Familial adenomatous polyposis . Restorative
proctocolectomy . Cell proliferation . Apoptosis and
carcinogenesis
Introduction
Familial adenomatous polyposis (FAP) is an autosomal-
dominant disease with an estimated prevalence of 1 in
5,000 to 1 in 7,500 [5]. It is characterized by the
development of hundreds of adenomas in the large
intestine. Without surgical intervention, virtually all
patients will develop colorectal cancer at relatively young
age.
To eliminate the risk of colorectal cancer, a restorative
proctocolectomy with ileal pouch anal anastomosis (IPAA)
is accepted as one of the surgical treatments of choice in
these patients.
In the IPAA procedure, almost all colonic mucosa is
resected, thus reducing cancer risk significantly. How-
ever in patients with FAP, adenomas are also present in
the upper gastrointestinal tract; approximately 5% of the
patients having gastric, 60 to 90% duodenal [4], 50%
jejunal [14], and 9 to 25% ileal adenomas [14, 23, 34].
Occurrence of ileal adenomas is of special interest
because the terminal ileum, which is used to construct
the pouch, may already contain adenomas. There is
accumulating evidence that adenomas develop in the
pouch. The reported incidence after a follow-up of at
least 5 years is 8 to 60%, increasing up to 75% in certain
subgroups [14, 26, 33, 38], which is much higher as
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compared to the reported incidence of 9–25% in the
preoperative ileum of patients with FAP [14, 23, 34].
Therefore, it seems that in the ileal pouch of patients with
FAP, the development of adenomas is accelerated. At
present, the malignant potential of the pouch adenomas is
unclear. However, 13 patients with a carcinoma in the
pouch have been recently described in the literature [2, 3,
7, 9, 13, 24, 25, 29, 35–37].
Stasis in the pouch causes a change in the luminal
content, which is in close contact with the ileal mucosa.
There is an increase in the concentration of short-chain fatty
acids to colonic levels [10], an increase in anaerobic
bacterial counts resulting in a more colonic type of flora,
and an increased deconjugation and dehydroxylation of bile
acids by anaerobic bacteria [20, 21]. The intestinal flora
could play a role in initiation and promotion of colon
cancer by activation of various classes of carcinogens, such
as nitrosamines, polycyclic aromatic hydrocarbons, and
glycosides [17]. A direct link between intestinal bacterial
flora and tumor promotion in the APCMin/+ mouse model
for FAP has already been established [22].
Therefore, we hypothesize that the intraluminal ecolog-
ical changes in the pouch are responsible for enhanced
tumor formation in the mucosa of the pouch. Alteration of
cell kinetics in the mucosa, including a lower rate of
apoptosis and a higher rate of cell proliferation, is
associated with tumor initiation and promotion. In colorec-
tal cancer, the balance between apoptosis, cell proliferation,
and cell shedding is disturbed, and such changes may favor
the development of adenomas [30]. Up to now, no data are
available on changes in proliferation and apoptosis rates of
the ileal mucosa of the pouch after IPAA in patients with
FAP.
The aim of this study is to investigate changes in
apoptosis and cell proliferation rates, occurring in the
mucosa of the pouch of patients with FAP, in comparison
with the ileum of the afferent loop. The results may
contribute to a better understanding of the enhanced




The study was approved by the regional medical ethical
commission, and informed consent was obtained from all
patients.
Patients with FAP and an IPAA, who were under
surveillance in the Radboud University Nijmegen Medical
Centre or regional affiliated hospitals, were invited to
participate in this study. Thirty-two patients with FAP were
included. The diagnosis FAP was based on either a clinical
presentation of at least 100 colonic adenomas or a mutation
in the APC gene. Data concerning the surgical procedures
were obtained from medical records.
From each patient, mucosal biopsy specimens of both
the pouch and the afferent ileal loop were obtained during a
regular surveillance endoscopy, in the period January 2002
until April 2004. Patients were fasted overnight. On the day
of examination, patients were encouraged to drink liberally.
No laxatives or cathartic enemas were given. To clear the
pouch of fecal ruminants, two 250-ml water enemas were
given before the endoscopy.
The endoscopy was performed with an Olympus GIF-
1T140 video endoscope. From January 2002 until August
2003, a 2.8-mm diameter biopsy forceps (FB 13K-1
Olympus, Tokyo, Japan) was used, and from September
2003 until April 2004, a 3.0-mm diameter biopsy forceps
(B102-C1-30.160 MedWork/Treier Endoscopie GA, Bero-
münster, Switzerland) was used. The afferent loop was
introduced up to 20 cm proximal of the pouch. The mucosa
was sprayed with 1% indigo carmine dye (Laboratoires
SERB, Paris) at 1:1 dilution with water, where after
photographs were taken to evaluate number and size of
adenomas present.
For pathological examination, at least four biopsies were
taken at random locations from the afferent ileal loop (10 to
20 cm proximal from the pouch), four biopsies from the
pouch mucosa (at least 5 cm proximal from the anal verge),
and four biopsies from adenomas if present. The biopsies
from adenomas were used only for pathological evaluation,
i.e., to exclude serious dysplasia in pouch adenomas, and
were not used for research purposes. The biopsies were
stretched on filter paper to maintain correct orientation of
crypts, fixated in formalin, and embedded in paraffin.
Immunohistochemistry
Cell proliferation and apoptosis were measured in the
stretched formalin-fixed nonadenomatous tissue. The crypt
cell proliferation activity was assessed after staining with
the monoclonal antibody MIB-1 (Dako A/S, Glostrup,
Denmark), which recognizes the Ki-67 nuclear antigen of
dividing cells in formalin-fixed paraffin-embedded tissue
[8]. Apoptosis was assessed by staining with the monoclo-
nal antibody M30 (Roche Diagnostics, Mannheim, Ger-
many), which recognizes cleaved cytokeratin 18.
Immunoreactivity of M30 is confined to the cytoplasm of
apoptotic epithelial cells and is expressed during early
apoptosis [18].
Tissue sections of 4-μm thickness were cut from paraffin
blocks, mounted on electrostatic slides (Super Frost Plus,
Menzel-Gläser, Germany), and dried overnight, followed
by drying in a stove at 50°C for 15 min.
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Sections were put in xylol for 10 min and taken from
xylol through 100% alcohol to water. After deparaffiniza-
tion, endogenous peroxidase was blocked by treatment with
3% hydrogen peroxide in phosphate-buffered saline (PBS)
for 30 min. Pretreatment was performed by heating the
tissue sections in citrate buffer (10 mmol/l, pH 6.0) at 180-
W power in a microwave oven for 10 min. After cooling at
room temperature for 1.5 h, sections were rinsed with PBS.
Then, 20% normal horse serum (Vector Laboratories,
Burlingame, CA, USA) was applied for 10 min. The
sections were then incubated overnight at 4°C with either
the mouse monoclonal antibodies MIB-1 at 1:1,000 dilution
or M30 at 1:100 dilution.
Thereafter, the sections were rinsed in PBS for 10 min
and incubated with biotinylated horse anti-mouse IgG
(Vector) for 30 min. After rinsing for 10 min in PBS,
incubation with ‘avidin and biotinylated horseradish perox-
idase macromolecular complex’ (Vector) was performed for
45 min. Finally, 5 mg/10 ml diaminobenzidine was used as
chromogen, and the sections were put in 0.5% CuSO4/0.9%
NaCl for 5 min to intensify the staining. Mayer hematox-
ylin counterstaining was applied. Sections were dehydrated
through 100% alcohol, cleared in xylol, and coverslipped
with permount (Fisher Scientific, Fiar Lawn, NJ, USA).
Tissue sections of rectal carcinoma were used as positive
controls.
Evaluation of immunostaining results
Investigators were blinded for the origin of the tissue
sections, regarding patient and biopsy location.
For evaluation of M30 staining, tissue sections were
examined by light microscopy. M30 positivity was identi-
fied as brown cytoplasmic staining. M30-positive cells
were marked by a first investigator (BvH) and reevaluated
by an expert pathologist (IN). In all cases, the complete
section was evaluated, and all M30-positive epithelial cells
were counted. The apoptotic index was expressed as the
number of M30-positive cells per tissue area in square
millimeters. Tissue area was assessed by using a Zeiss
KS400 computer-aided system.
In each MIB-1-immunostained tissue section, crypts
whose entire length could be visualized were photographed
under ×400 magnification using a Zeiss KS400 computer-
aided system. Crypts were excluded when they did not
reach the muscularis mucosae or had multilayered bases.
MIB-1 positivity was identified as brown nuclear
staining. The number of MIB-1-positive epithelial cells
and the total number of epithelial cells in up to five crypts
per tissue section were counted from screen. The labeling
index for each crypt was given by the ratio of MIB-1-
positive cells and the total number of crypt epithelial cells
and is expressed as percentage of total. For each patient, the
labeling indices of pouch and afferent ileal loop were
expressed as means of three to five counted crypts. If less
than three crypts could be photographed for either pouch or
ileal loop, the patient was excluded from analysis. The
photographed crypts of five randomly selected patients
were counted twice by one investigator (BvH) to determine
intraobserver variability.
Although great effort was made to obtain well-orientated
mucosal crypts when using the quantitative method,
however, not all biopsies reached the criteria mentioned
above, and therefore, could not be examined. This problem
mainly occurred in the biopsies taken from the pouch and
might be due to friability of the pouch mucosa. We
therefore developed a new semiquantitative scoring system.
A representative part of the biopsies showing several
complete crypt/villous axes was photographed under ×100
magnification. The photographs were judged pair-wise
(pouch vs afferent loop) during which the investigators
had to choose from four possible outcomes; one of the two
locations showed most MIB-1 positivity. MIB-1 positivity
did not differ or no judgement could be made. Judgement
was based on relative length of the area of positive cells and
the relative size of the stem cell compartment. Five
investigators, two pathologists (IN, HvK), two gastro-
enterologists (PF, FN), and one junior investigator (BvH)
independently compared the paired photographs of biopsies
of pouch and afferent ileal loop of all patients. When three
or more observers agreed in their judgement, this judge-
ment was denoted as consensus judgement. If this criterion
was not met, no consensus was reached. If the quality of the
tissue sections was poor, no judgment was made. One
investigator (BvH) judged the whole series twice for
evaluation of intraobserver reliability.
Statistical analyses
Values for apoptosis and cell proliferation in the quantita-
tive study were not expected to be normally distributed;
therefore, they were presented as median and range. The
Wilcoxon matched-pairs signed-ranks test was used to
compare the paired observations in the apoptosis staining
and the paired mean labeling indices in the cell proliferation
study.
Consensus judgements on the semiquantitative assess-
ment of cell proliferation, favoring either pouch or ileal
afferent loop, were compared with a Sign test. To evaluate
the reliability of this semiquantitative method to assess cell
proliferation, Cohen’s kappa was calculated for the first and
second series of judgements by the prime investigator to
determine intraobserver reliability. Also, for each pair of
investigators, a Cohen’s kappa was calculated. The mean
Cohen’s kappa was taken as value for interobserver
reliability.
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Consensus judgments were compared to the difference in
mean labeling index between pouch and ileal afferent loop
for each evaluable patient.
A p value less than 0.05 was considered as significant
(SPSS for Windows 11.0.1, 2001).
Results
Patient characteristics
Patient characteristics are given in Table 1. The median age
of the 32 patients (19 men, 13 women) included in the
study was 32 (range 16–72) years.
Twenty-three patients were operated in the Radboud
University Nijmegen Medical Centre. The median age at
the time of reconstructive colectomy was 24 (range 10–55)
years. A mucosectomy with hand-sewn IPAA was per-
formed in 9 patients, and a double-stapled IPAA was
performed in 21 patients. For two patients, the information
about the performed technical procedure could not be
retrieved. At the moment of colectomy, four patients had a
colorectal adenocarcinoma localized in the rectum, sigmoid,
hepatic flexure, or appendix, respectively.
At the time of endoscopy, the median age of the pouch
was 96 (range 9–216) months. The medication used was
loperamide by 18 patients, psyllium fibres by 3 patients, and
iron, metoclopramide, colestyramine, omeprazole, sulindac,
tramadol, tamoxifen, gosereline, nifedipine, metoprolol,
furosemide, or losartan each by 1 patient. Thirteen patients
were not on medication 3 months before endoscopy.
One patient used sulindac, a nonspecific cyclooxygenase
inhibitor, which is thought to influence cell proliferation
and especially apoptosis [15, 27]. Exclusion of this patient
from analyses had no effect on the results.
Histological examination revealed pouch adenomas in
24 patients (75%).
Apoptosis
In both pouch and afferent ileal loop, M30-positive cells
were predominantly detected in the mucosal villi (Fig. 1).
In the 32 pairs of biopsies from pouch and afferent ileal
tissue investigated, the median absolute number of apopto-
tic cells in the pouch mucosa was two per tissue section
(range 0–9), which was identical to the values in the
afferent ileal loop (2, range 0–19). The median apoptotic
index (expressed as number of M30-positive cells per mm2
tissue section area) did not differ between pouch (median
0.4/mm2, range 0–2.9) and afferent ileal tissue (median 0.3,
range 0–2.7; see Fig. 2).
Cell proliferation
Quantitative comparison
The intraobserver reliability for counting of the photo-
graphed crypts (Fig. 3) was rs=0.855, p=0.002.
In 12 pouch tissue sections, less than three crypts were
available for counting, and these samples were therefore
excluded from analysis. For the same reason, two afferent
ileal tissue sections were excluded. In the 20 pairs of pouch
and afferent ileum tissue sections left for comparison,
median labeling index (expressed as percentage of MIB-1-
positive epithelial crypt cells) was significantly higher in
Table 1 Patient characteristics
Apoptosis Cell
proliferation
Number of patients studied 32 20
Male/Female 19/13 12/8
Median age in years (range) 32 (16–72) 29 (16–62)
Median age at surgery in years (range) 24 (10–55) 20 (10–52)




Carcinoma at surgery 4 0
Patients with adenomas at biopsy:
yes/no
24/8 15/5
For quantitative cell proliferation analysis, 12 patients had to be
excluded from analysis (right column) due to absence of sufficient
evaluable crypts (see under “Materials and methods”).
Fig. 1 Apoptotic epithelial cells
(encircled) using M30 immuno-
histochemistry. Original magni-
fication ×200 (left) and ×400
(right)
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the pouch as compared to the afferent ileum (median
68.3%, range 52.9–79.6% vs median 61.6%, range 38.0–
73.9%; Wilcoxon signed-ranks test, p=0.001; Fig. 4).
Semiquantitative comparison
The results of the semiquantitative comparison of the
photographed tissue sections from the pouch and afferent
ileum mucosae (Fig. 5) are visualized in Fig. 6. In 15
patients (47%), the proliferation was higher in the pouch; in
7 patients (22%), there was no difference; in 5 patients
(16%), proliferation was higher in the afferent ileal loop; in
2 patients (6%), no consensus could be achieved; and in 3
patients (9%), no judgement was possible due to poor
quality of the tissue sections. These differences were
significant (p<0.05).
Intraobserver reliability was κ=0.87. Cohen’s kappa for
each pair of observers ranged from 0.26 to 0.59 with a
mean Cohen’s kappa of 0.38, which corresponds with “fair
agreement” following Byrt’s guidelines [6]. Thus, interob-
server reliability was acceptable.
In cases in which a labeling index could be assigned to
both pouch and afferent ileal loop, consensus judgment was
available in 18 cases (Fig. 7). In all cases in which the
semiquantitative analyses showed more proliferation in the
pouch (n=11), this was confirmed by the quantitative
method; the median value of the difference in proliferation
between pouch and ileum was 0.107 (range 0.032–0.175).
In the five cases where no difference was observed with the
semiquantitative approach, the median value of the differ-
ence in proliferation between pouch and ileum was 0.023
(range −0.096 to 0.120). There were only three cases in
which the semiquantitative method showed more prolifer-
ation in the afferent loop, and the median value of the
difference in proliferation between pouch and ileum in
these cases was 0.098 (range −0.021 to 0.262). The
Spearman’s correlation coefficient between the semiquan-
titative and the quantitative methods was 0.273 (p=0.244).
Discussion
Although both the pouch and its afferent loop contain the
same preexisting ileal mucosa, adenomas occur more
frequently in the pouch of patients with FAP than in the
afferent ileal loop, suggesting an accelerated adenoma
formation in the pouch [14, 26, 33, 38]. To investigate the
Fig. 3 Detection of proliferating crypt cells with MIB-1 immunohis-
tochemistry. Brown stained nuclei are positive. Nonproliferative crypt
stem cells are visualized at the base of the crypt. Original
magnification ×400
Fig. 2 Box-Whisker plots of apoptosis expressed as number of M30-
positive epithelial cells per mm2 tissue section area of pouch and
afferent ileum of 32 patients with FAP. Difference between groups was
not significant. Values are given as median (fat line), lower to upper
quartile (green box), and minimum and maximum values (error bars)
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role of cell kinetics as a possible explanation for this
observation, apoptosis and cell proliferation rates in the
mucosa of the pouch were compared with those of the
afferent ileal loop from the same patient to eliminate bias
caused by interindividual differences. Cell proliferation was
significantly higher in the pouch mucosa in comparison to
mucosa of the afferent ileal loop. No significant difference
in apoptosis was found in the mucosa of the pouch and
afferent ileal loop.
A low amount of apoptotic cells in the pouch as well as
in the ileal mucosa was found. This might be caused by the
APC mutation-induced apoptotic resistance [16]. Only a
trend but no significant difference in apoptosis was found.
Taking into account the broad range of apoptotic rates as
found in our study samples, a significant difference might
be found when a larger group of patients could be studied.
There are no clear guidelines for estimation of ileal
proliferation. For estimation of colonic proliferation, an
accepted method is to count proliferating cells in five
colonic crypts. Although most biopsy specimens were
stretched and orientated directly after endoscopy, only a
lower number of crypts could be counted completely along
the longitudinal axis in most patients. For this reason, we
accepted three full crypts as the minimal number to assess
proliferation. Using this criterion, tissue sections from 12
patients still could not be used to determine the cell
proliferation and had to be excluded from the study.
Especially in the tissue sections of the pouch, this problem
was evident and is possibly caused by a higher fragility of
this tissue. In the remaining 20 pairs of tissue sections left
Fig. 5 Photographs used for
semiquantitative comparison of
cell proliferation in MIB-1
immunohistochemically stained
tissue sections of pouch (left)
and afferent ileal mucosae
(right; original magnification
×100)
Fig. 4 Box-Whisker plots of cell proliferation expressed as median
labeling index (MIB-1-positive crypt cells per total number of crypt
cells) of 3–5 crypts in tissue sections of pouch and afferent ileum of
20 patients with FAP. Difference between groups was significant (p=
0.001). Values are given as median (fat line), lower to upper quartile
(red box), and minimum and maximum values (error bars)
Fig. 6 Histogram of semiquantitative comparison; 0 ileal mucosa
shows more cell proliferation than pouch mucosa, 1 no difference in
cell proliferation between pouch and ileal mucosae, 2 pouch mucosa
shows more cell proliferation than ileal mucosa, 3 no judgement
possible, 4 no consensus could be reached
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for comparison, we found a significantly higher median
labeling index in the pouch compared to the ileal afferent
loop.
To overcome the problem of the relative low number of
assessable crypts, another quicker but less quantitative
method was applied in which five investigators compared
photographs of tissue sections of pouch and ileal mucosae.
In accordance with the results of the first method, we found
significantly higher cell proliferation in the mucosa of the
pouch compared to that of the ileal mucosa. Although no
significant correlation could be found in a case-by-case
comparison between both methods, in all cases in which the
semiquantitative analyses showed more proliferation in the
pouch, this was confirmed by the quantitative analyses of
crypts. Furthermore, the inter- and intraobserver variability
was good.
In addition, the semiquantitative method is far less time-
consuming and can therefore give a relatively fast and easy
impression of eventual differences in cell proliferation.
Evaluation of this method in a larger study may further
demonstrate its value.
Data on cell proliferation in ileal mucosa in patients with
FAP are limited. Previously, de Silva et al. [11] reported a
labeling index of 19.8% in afferent ileal loop mucosa of
patients with FAP or ulcerative colitis (UC), far lower than
the 61.6% that was found here. Their labeling index for cell
proliferation in ileal pouch mucosa (33.6%) was also much
lower than in the present study. Only the labeling index of
51.7% as found by them in pouches with pouchitis nears
the values we obtained. However, the majority of patients
included in the study of de Silva et al. were patients with
UC (23 of the 26 patients), so direct comparison with our
results therefore seems inappropriate. In addition, Goldberg
et al. [12] reported a median labeling index of 34.9% in the
ileal pouch of patients with FAP, which is much lower than
the 68.3% we found. However, their labeling indices were
based on a minimum of three counted crypts, and if this
number could not be reached, halves of crypts were
included in the analyses. Moreover, their study group
consisted of only 5 patients with FAP, whereas in the
present study, 3 to 5 whole crypts of 20 patients were
counted.
Several studies indicated that cell proliferation of
normal-appearing colorectal mucosa of patients with ade-
nomas or carcinomas was 19 to 86% higher compared to
colorectal mucosa of healthy persons [1, 28, 30, 32]. These
findings strongly suggest an association between the
presence of adenomas or carcinomas and an increased
mucosal cell proliferation. However, the difference in cell
proliferation between pouch and afferent ileal mucosae of
6.7% as found in this study is less pronounced in
comparison to the above referred findings. A possible
explanation for this relatively small difference in cell
proliferation between pouch and ileal mucosae in our study
may be that intestinal epithelial cell proliferation is already
very high in patients with FAP [19, 31], and these high cell
proliferation rates make a further increase less pronounced.
The higher proliferation found in the pouch mucosa in
comparison to mucosa of the afferent ileal loop can only
be explained by intraluminal changes that occur after
construction of the pouch. Whether changes in bacterial
flora, bile acid composition, short-chain fatty acids, or
other compounds are responsible for this finding remains
unclear, but a better understanding of this process is
necessary to find a possible treatment for this group of
patients.
In conclusion, the increased cell proliferation in the
ileal pouch mucosa compared to the mucosa of the
afferent ileal loop may contribute to the enhanced risk
for adenomas and carcinomas in the pouch of patients
with FAP and emphasizes the need for regular endo-
scopical surveillance of the pouch in these patients. In
addition, cell proliferation can be used as an early
endpoint marker in chemopreventive studies in these
patients.
The applied new method for semiquantitative evalua-
tion of cell proliferation in immunohistochemically
stained tissue sections seems promising, as it offers a
relatively fast and easy means of assessment.
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Fig. 7 Semiquantitative comparison vs difference in mean labeling
index of pouch minus afferent ileal mucosa; 0 ileal mucosa shows
more cell proliferation compared to the pouch mucosa, 1 no difference
in cell proliferation between pouch and ileal mucosae, 2 pouch
mucosa shows more cell proliferation compared to the ileal mucosa
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